Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl / 6 mice
Đã lưu trong:
| Tác giả chính: | |
|---|---|
| Ngày xuất bản: | 2014 |
| Tác giả khác: | , , , , |
| Định dạng: | Article |
| Ngôn ngữ: | eng |
| Nguồn: | Repositório Institucional da UnB |
| Download full: | http://repositorio.unb.br/handle/10482/29126 https://dx.doi.org/10.1590/0037-8682-0202-2013 |
Tóm tắt: | Introduction The treatment of leishmaniasis ischallenging, given the difficulties in drug administration and resistance. Therefore, we chose to test the efficacy of miltefosine combined with pentoxifylline. Methods Twenty-seven isogenic C57Bl/6 mice were infected with Leishmania (Leishmania) amazonensis, and equally divided into three groups: miltefosine (200mg/kg/day), miltefosine (200mg/kg/day) with pentoxifylline (8mg/kg/day), and untreated. Response to treatment was evaluated using paw diameter and parasitological criteria. Results The number of viable Leishmania reduced significantly within the miltefosine-pentoxifylline group (p < 0.05). Conclusions There is hope that a viable treatment exists for Leishmania infection. |
Những quyển sách tương tự: Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl / 6 mice
- Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil : a randomized and controlled trial
- Eficácia da associação de medicamentos orais e tópico no tratamento de leishmaniose cutânea causada por Leishmania (Viannia) braziliensis em camundongos BALB/c
- Estudo piloto randomizado e controlado, usando a Associação de Miltefosina e Pentoxfilina para avaliar a cura clinica e efeitos adversos no tratamento de pacientes com Leishmaniose Tegumentar Americana em Área Endemica de L. (V) braziliensis
- Recurrent cutaneous leishmaniasis
- Action of pentoxifylline on experimental cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis
- Estudo comparativo entre miltefosina oral e antimoniato de N-metil glucamina parenteral no tratamento da leishmaniose experimental causada por Leishmania (Leishmania) amazonensis
